Literature DB >> 29742985

Laparoscopic Redo Ileocolic Resection for Crohn's Disease in Patients with Previous Multiple Laparotomies.

V Celentano1, F Sagias1, K G Flashman1, J Conti1, J Khan1.   

Abstract

PURPOSES:: Over 80% of patients with primary ileocolic Crohn's disease have a surgical resection within 10 years of diagnosis, and 40%-50% of them need further surgery within 15 years. Laparoscopic surgery can be challenging due to a thickened mesentery and the potential for fistulas, abscesses, and phlegmons. Aim of this study is to analyze the short-term outcomes of laparoscopic redo ileocolic resections for Crohn's disease in patients with previous multiple laparotomies.
METHODS: : All patients undergoing laparoscopic surgery for ileocolic Crohn's disease from March 2006 to February 2017 were prospectively evaluated. Short term outcomes of laparoscopic ileocolic resection were compared between patients with previous multiple major surgeries and recurrent Crohn's disease, and patients undergoing surgery for the first presentation of Crohn's disease and no history of previous surgery. Conversion rate and 30-day morbidity were the primary outcomes. Reoperations, readmissions, operating time and length of stay were the secondary outcomes.
RESULTS: : 29 patients with recurrent Crohn's disease and previous multiple laparotomies were included: the number of laparotomies these patients previously underwent was 2 in 19 cases (65.5%), 3 in 9 (31%), and 4 in 1 (3.5%). In total, 90 patients with no history of any previous abdominal surgery, who underwent laparoscopic ileocecal resection for Crohn's disease, represented the control group. No differences were found in morbidity and conversion rate. Operating time was longer in patients with history of previous abdominal surgery.
CONCLUSION: : Laparoscopic redo ileocolic resection for Crohn's disease is feasible and safe in patients with previous multiple laparotomies at the expense of longer operating time.

Entities:  

Keywords:  Crohn’s disease; ileocecal resection; laparoscopic colorectal surgery; redo surgery

Mesh:

Year:  2018        PMID: 29742985     DOI: 10.1177/1457496918772370

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  6 in total

1.  Biological therapy prior to repeat ileocolic resection in Crohn's disease can reduce the postoperative complication rate.

Authors:  N Horesh; M R Freund; Z Garoufalia; R Gefen; D Zhang; T Smith; S H Emile; S D Wexner
Journal:  Tech Coloproctol       Date:  2022-09-29       Impact factor: 3.699

2.  Risk factors and predictors of 30-day complications and conversion to open surgery after repeat ileocolic resection of Crohn's disease.

Authors:  Sameh Hany Emile; Michael R Freund; Nir Horesh; Zoe Garoufalia; Rachel Gefen; Emanuela Silva-Alvarenga; Steven D Wexner
Journal:  Surg Endosc       Date:  2022-09-06       Impact factor: 3.453

3.  The safety and feasibility of laparoscopic redo surgery for recurrent Crohn's disease: A comparative clinical study of over 100 consecutive patients.

Authors:  Takayuki Ogino; Yuki Sekido; Tsuyoshi Hata; Norikatsu Miyoshi; Hidekazu Takahashi; Mamoru Uemura; Hirofumi Yamamoto; Yuichiro Doki; Hidetoshi Eguchi; Tsunekazu Mizushima
Journal:  Ann Gastroenterol Surg       Date:  2021-12-16

4.  Laparoscopic redo surgery in recurrent ileocolic Crohn's disease: A standardised technique.

Authors:  Valerio Celentano
Journal:  J Minim Access Surg       Date:  2020 Jan-Mar       Impact factor: 1.407

5.  Single-incision laparoscopic surgery (SILS) for the treatment of ileocolonic Crohn's disease: a propensity score-matched analysis.

Authors:  Valerio Celentano; Gianluca Pellino; Matteo Rottoli; Francesco Colombo; Gianluca Sampietro; Antonino Spinelli; Francesco Selvaggi
Journal:  Int J Colorectal Dis       Date:  2020-12-23       Impact factor: 2.571

6.  Longer small bowel segments are resected in emergency surgery for ileocaecal Crohn's disease with a higher ileostomy and complication rate.

Authors:  V Celentano; D P O'Leary; A Caiazzo; K G Flashman; F Sagias; J Conti; A Senapati; J Khan
Journal:  Tech Coloproctol       Date:  2019-10-29       Impact factor: 3.781

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.